Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
78 hedge funds and large institutions have $848M invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
11% less funds holding
Funds holding: 88 → 78 (-10)
16% less capital invested
Capital invested by funds: $1.01B → $848M (-$166M)
43% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 35
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $6K | Put options by funds: $2.85M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$7.36M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.17M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$736K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$625K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$539K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.1M |
| 2 |
BlackRock
New York
|
-$3.16M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.63M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$2.39M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.8M |
ODT Hedge Fund Activity: Q1 2020 in Review
78 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q1 2020, worth a combined $848M — down 16% from $1.01B a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ODT and 5 opened new positions — a net loss of 8 holders — while 35 trimmed existing stakes and 20 added.
The largest buyer was Janus Henderson Group, adding an estimated $7.36M. The largest seller was Wellington Management Group, cutting an estimated $5.1M.
- 78 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q1 2020, down from 88 in Q4 2019.
- Funds reported $848M of Odonate Therapeutics, Inc. Common Stock stock for Q1 2020, down 16% quarter-over-quarter.
- 5 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q1 2020 and 13 closed out, a net change of -8 holders.
- The largest Odonate Therapeutics, Inc. Common Stock buyer in Q1 2020 was Janus Henderson Group, an estimated $7.36M added.
- The largest Odonate Therapeutics, Inc. Common Stock seller in Q1 2020 was Wellington Management Group, an estimated $5.1M sold.
Based on aggregated 13F filings for Q1 2020.